Medicxi
Overview
Medicxi is a European life sciences investment firm that specializes in drug discovery and therapeutic development by creating, investing in, and supporting biotech companies across the full drug development continuum.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Altesa BioSciences | Feb 2026 | Series B | Co-investor |
| Diasome Pharmaceuticals | Jul 2017 | Series A | Lead |
| Fore Biotherapeutics | Jul 2026 | Series D-2 Extension | Lead |
| SynOx Therapeutics | Nov 2020 | Series A | Lead |
| Alderaan Biotechnology | Jan 2020 | Series A | Lead |
For institutional investors. Book with your work email.
Key People
Giuseppe Zocco
Co-Founder And Partner
Richard Lee
Co-Founder And Operating Partner
Benjamin Perry
Venture Partner
Charles Grummitt
Venture Partner
João Vieira
Venture Partner
Marco Prunotto
Venture Partner
Stephen Rapecki
Venture Partner
Thibaut De Smedt
Venture Partner
Giovanni Mariggi
Partner
Giovanni Pericolini
Partner And CFO
Shyam M.
Principal
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Medicxi based?
Medicxi is headquartered in London, United Kingdom.
When was Medicxi founded?
Medicxi was founded in 2016.
How many portfolio companies does Medicxi have?
Medicxi has 30 portfolio companies in Caplight's dataset.
What are some companies in Medicxi's portfolio?
Portfolio companies visible on Caplight include Altesa BioSciences, Diasome Pharmaceuticals, Fore Biotherapeutics, SynOx Therapeutics, Alderaan Biotechnology.
What was Medicxi's most recent investment shown here?
Medicxi's most recent investment in this portfolio sample was in Fore Biotherapeutics in 2026.
What sectors does Medicxi focus on?
Medicxi focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Medicxi focus on?
Medicxi typically invests at the MultiStage stage.
What is Medicxi's AUM?
Medicxi's assets under management are estimated between $500.0M and $1.0B.